Form 4 for ELV Elevance Health
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001748691-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-02+ | ELV | Kaye Mark | EVP, CFO | F - Tax | $288.39 | -624 | 15.8K | -4% | -$180.0K |
| DM | 2026-03-04 | 2026-03-02 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +16.6K | 22.2K | +296% | $0 |
| D | 2026-03-04 | 2026-03-02 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +25.2K | 25.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | F | D | 353 | $284.03 | 32,037 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2026-03-02 | F | D | 271 | $294.07 | 15,811 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 3 | Common | Common Stock | 2026-03-02 | A | A | 10,202 | $0.00 | 32,390 | D | — | — | (F3) Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028. |
| 4 | Common | Common Stock | 2026-03-02 | A | A | 6,377 | $0.00 | 22,188 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | A | A | 25,188 | $0.00 | 25,188 | D | $294.07 · — to 2036-03-02 | 25,188 Common Stock | (F4) The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. |